Symbol not found

:CYDY   00:00AM GMT
0.00
0.00 (0.00%)
Products

Cytodyn Submits The First Of Three Main Sections Of HIV BLA To FDA Under Previously Authorized Rolling Review

Published: 11/16/2021 11:13 GMT
(CYDY) - Cytodyn Submits the First of Three Main Sections of Hiv Bla to FDA Under Previously Authorized Rolling Review.
Cytodyn Inc - Clinical Section (last Portion to Complete Hiv Bla) Expected to Be Submitted During Q1 2022.